These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 921238)

  • 21. Inhibition and potentiation of platelet function by lysolecithin.
    Joist JH; Dolezel G; Cucuianu MP; Nishizawa EE; Mustard JF
    Blood; 1977 Jan; 49(1):101-12. PubMed ID: 830368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cytostatics on some platelet functions in vitro. V. Hydroxyurea.
    Kubisz P; Parizek M; Kovácová J; Cronberg S
    Acta Haematol; 1977 Mar; 57(4):242-46. PubMed ID: 403729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
    Klener P; Kubisz P; Suranová J
    Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers.
    Tartaglione TA; Duma RJ; Qureshi GD
    Antimicrob Agents Chemother; 1986 Jul; 30(1):73-7. PubMed ID: 3752983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human platelet function by sulfatides.
    Devaiah AK; Raife TJ; Barton JA; Olson JD
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial inhibition of platelet aggregation by nebulized pentamidine in severe haemophiliacs.
    Cattaneo M; Lecchi A; Tradati F; Lombardi R; Zighetti ML; Guarneri D; Mannucci PM
    Haemophilia; 1997 Jan; 3(1):31-4. PubMed ID: 27214616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregation of washed platelets from non-anticoagulated human blood is not reversible.
    Bowry SK; Müller-Berghaus G
    Thromb Haemost; 1986 Oct; 56(2):172-7. PubMed ID: 3101220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nicotine on platelet function.
    Pfueller SL; Burns P; Mak K; Firkin BG
    Haemostasis; 1988; 18(3):163-9. PubMed ID: 3181816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human platelet acetylcholinesterase: the effects of anticholinesterases on platelet function.
    Smith MJ; Braem B; Davis KD
    Thromb Haemost; 1980 Feb; 42(5):1615-9. PubMed ID: 7368161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of imidazole carboxamide on platelet functions and coagulation in vitro.
    Klener P; Kubisz P
    Am J Med Sci; 1978; 275(2):181-6. PubMed ID: 665720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.